ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 091,86
-0,17%
Dow Jones
38 460,92
-0,11%
DAX
18 077,71
-0,36%
Brent Oil
87,17
-0,45%
Bitcoin
64 046,25
-3,56%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. L'Europe
  5. EU
  6. Mithra Pharmaceuticals SA (MITRA)

  7. Mithra Pharmaceuticals SA (MITRA) Actualités

MITRA Mithra Pharmaceuticals SA

0,2215
-0,0055 (-2,42%)
24 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Mithra Pharmaceuticals SA MITRA Euronext Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0055 -2,42% 0,2215 17:40:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,23 0,2215 0,23 0,2215 0,227
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/4/202407:00GLOBEMithra secures court protection measures to advance..
08/3/202407:00GLOBEMithra reports full year 2023 financial results
05/3/202407:01GLOBEMithra announces changes to its executive management
05/3/202407:00GLOBEMithra initiates monetization process, receives bridge loan..
29/2/202411:42GLOBEDONESTA® safety study for menopause completes treatment..
15/2/202418:23GLOBEMithra sells shares in Mayne Pharma
06/2/202407:00GLOBEMithra updates on cash position
21/12/202317:45GLOBEMithra and Rafa Laboratories sign binding Head of Terms to..
20/12/202317:45GLOBEMithra Completes Pediatric Study of ESTELLE® in Adolescent..
18/12/202307:00GLOBEMithra Receives Positive DSMB Opinion on DONESTA® European..
04/12/202307:00GLOBEMithra and Gedeon Richter sign binding Head of Terms to..
30/11/202307:00GLOBEMithra receives guidance from the FDA for the DONESTA® NDA..
28/11/202317:45GLOBEMithra to hold five presentations on key role of estrogens..
07/11/202307:00GLOBEMithra’s NEXTSTELLIS® granted additional patent in the..
06/11/202318:52GLOBEMithra releases invitation to its extraordinary securities..
26/10/202307:00GLOBEMithra and Searchlight Pharma sign DONESTA® licensing..
23/10/202307:00GLOBEMithra to receive EUR 2.5 million milestone payment from..
17/10/202307:00GLOBEMithra’s Board of Directors to propose the removal of its..
11/10/202307:15GLOBEShareholder Letter
11/10/202307:00GLOBEMithra announces update to the agenda of its upcoming..
10/10/202318:00GLOBEMithra to Hold Presentations on Key Role of Estrogens in..
05/10/202307:00GLOBEMithra Provides an Update in the Context of Recent Market..
27/9/202307:00GLOBEMithra Announces Presentation of Positive Data on Estetrol..
26/9/202307:00GLOBEMithra Financial Results for First-Half 2023
22/9/202313:30GLOBEMithra présentera ses résultats financiers du premier..
21/9/202317:55GLOBEMithra to Hold Investor Call on H1 2023 Financial Results on..
12/9/202317:45GLOBENotice of Adjustment of the Conversion Price of Mithra's EUR..
11/9/202307:30GLOBELetter to Shareholders and Corporate Update
28/8/202317:45GLOBEMithra completes EUR 20 million private placement in equity..
24/8/202307:33GLOBEMithra prices private placement to raise EUR 20 million in..
08/8/202307:30GLOBEMithra and Gedeon Richter Sign Supply Agreement for..
03/8/202307:30GLOBEMithra Receives EUR 1.25 Million Milestone Payment from Fuji..
31/7/202307:30GLOBEMithra and Searchlight Pharma Announce Donesta® Licensing..
17/7/202317:45GLOBENotice of Adjustment of the Conversion Price of Mithra's..
04/7/202317:45GLOBENotice of Adjustment of the Conversion Price of Mithra's EUR..
26/6/202317:45GLOBEMithra Announces Information on the Total Number of Voting..
21/6/202320:38GLOBEMithra has access to the new EUR 12.5 million tranche of the..
15/6/202307:30GLOBEMithra Announces New Positive Preclinical Data from CSF-1R..
05/6/202317:45GLOBEMithra - Publication of a transparency notification received..
29/5/202307:30GLOBEMithra Appoints Experienced Life Sciences Executive..
25/5/202318:39GLOBEMithra’s General Meeting Of Shareholders Approves the..
25/5/202317:45GLOBEMithra’s General Meeting Of Shareholders Approves the..
25/5/202307:30GLOBEMithra - Letter to Shareholders and Corporate Update
12/5/202317:45GLOBEMithra Pharmaceuticals - Payment of the interests of the..
11/5/202307:30GLOBEMithra Announces Completion of Recruitment in Pediatric..
04/5/202307:30GLOBEMithra and the University of Liège Secure Proof-of-Concept..
28/4/202317:45GLOBEPublication of a transparency notification received from..
25/4/202307:30GLOBEMithra Releases Invitation to its General Shareholders’..

Dernières Valeurs Consultées

EU
MITRA
Mithra Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés